News Stories (2 Results) -
Marathon Asset Management
Dermavant Sciences entered into a $160 million revenue interest purchase and sale agreement for its investigational product tapinarof with three participants that include Marathon Asset Management (Marathon), NovaQuest Capital Management (NovaQuest)...
view press release
June 07, 2021, 07:00 AM
|
Marathon Asset Management announced the final close for its Marathon Distressed Credit Fund, which was oversubscribed with approximately $2.5 billion in commitments. The fund will invest in a wide range of situations by providing capital solutions...
view press release
January 08, 2021, 08:13 AM
|